These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12865385)

  • 1. Susceptibility of Bacillus anthracis to eleven antimicrobial agents including novel fluoroquinolones and a ketolide.
    Frean J; Klugman KP; Arntzen L; Bukofzer S
    J Antimicrob Chemother; 2003 Aug; 52(2):297-9. PubMed ID: 12865385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity.
    Athamna A; Massalha M; Athamna M; Nura A; Medlej B; Ofek I; Bast D; Rubinstein E
    J Antimicrob Chemother; 2004 Feb; 53(2):247-51. PubMed ID: 14688054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of Bacillus anthracis isolates resistant to antibiotics.
    Athamna A; Athamna M; Abu-Rashed N; Medlej B; Bast DJ; Rubinstein E
    J Antimicrob Chemother; 2004 Aug; 54(2):424-8. PubMed ID: 15205405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to antibiotics of Bacillus anthracis strains isolated in Romania.
    Caplan DM; Ivana S; Caplan ME
    Roum Arch Microbiol Immunol; 2009; 68(2):106-10. PubMed ID: 20361530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Yersinia pestis to novel and conventional antimicrobial agents.
    Frean J; Klugman KP; Arntzen L; Bukofzer S
    J Antimicrob Chemother; 2003 Aug; 52(2):294-6. PubMed ID: 12865386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type II topoisomerase mutations in Bacillus anthracis associated with high-level fluoroquinolone resistance.
    Bast DJ; Athamna A; Duncan CL; de Azavedo JC; Low DE; Rahav G; Farrell D; Rubinstein E
    J Antimicrob Chemother; 2004 Jul; 54(1):90-4. PubMed ID: 15190035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones.
    Brook I; Elliott TB; Pryor HI; Sautter TE; Gnade BT; Thakar JH; Knudson GB
    Int J Antimicrob Agents; 2001 Dec; 18(6):559-62. PubMed ID: 11738344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of Bartonella species to 17 antimicrobial compounds: comparison of Etest and agar dilution.
    Dörbecker C; Sander A; Oberle K; Schülin-Casonato T
    J Antimicrob Chemother; 2006 Oct; 58(4):784-8. PubMed ID: 16916864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae.
    Miyashita N; Fukano H; Yoshida K; Niki Y; Matsushima T
    J Antimicrob Chemother; 2003 Sep; 52(3):497-9. PubMed ID: 12917246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
    Athamna A; Athamna M; Medlej B; Bast DJ; Rubinstein E
    J Antimicrob Chemother; 2004 Apr; 53(4):609-15. PubMed ID: 14998982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of Bacillus anthracis, Bacillus cereus, Bacillus mycoides, Bacillus pseudomycoides and Bacillus thuringiensis to 24 antimicrobials using Sensititre automated microbroth dilution and Etest agar gradient diffusion methods.
    Luna VA; King DS; Gulledge J; Cannons AC; Amuso PT; Cattani J
    J Antimicrob Chemother; 2007 Sep; 60(3):555-67. PubMed ID: 17586563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.
    Brook I; Germana A; Giraldo DE; Camp-Hyde TD; Bolduc DL; Foriska MA; Elliott TB; Thakar JH; Shoemaker MO; Jackson WE; Ledney GD
    J Antimicrob Chemother; 2005 Dec; 56(6):1074-80. PubMed ID: 16239289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Bacillus anthracis-like bacteria isolated from wild great apes from Cote d'Ivoire and Cameroon.
    Klee SR; Ozel M; Appel B; Boesch C; Ellerbrok H; Jacob D; Holland G; Leendertz FH; Pauli G; Grunow R; Nattermann H
    J Bacteriol; 2006 Aug; 188(15):5333-44. PubMed ID: 16855222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis.
    Maples KR; Wheeler C; Ip E; Plattner JJ; Chu D; Zhang YK; Preobrazhenskaya MN; Printsevskaya SS; Solovieva SE; Olsufyeva EN; Heine H; Lovchik J; Lyons CR
    J Med Chem; 2007 Jul; 50(15):3681-5. PubMed ID: 17608397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility and molecular subtyping of 55 Turkish Bacillus anthracis strains using 25-loci multiple-locus VNTR analysis.
    Ortatatli M; Karagoz A; Percin D; Kenar L; Kilic S; Durmaz R
    Comp Immunol Microbiol Infect Dis; 2012 Jul; 35(4):355-61. PubMed ID: 22445310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Bacillus anthracis.
    Doğanay M; Aydin N
    Scand J Infect Dis; 1991; 23(3):333-5. PubMed ID: 1909051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Etest for antimicrobial susceptibility testing of Bartonella henselae.
    Wolfson C; Branley J; Gottlieb T
    J Antimicrob Chemother; 1996 Dec; 38(6):963-8. PubMed ID: 9023643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of Bacillus anthracis strains from Hungary.
    Kreizinger Z; Sulyok KM; Makrai L; Rónai Z; Fodor L; Jánosi S; Gyuranecz M
    Acta Vet Hung; 2016 Jun; 64(2):141-7. PubMed ID: 27342086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey.
    Esel D; Doganay M; Sumerkan B
    Int J Antimicrob Agents; 2003 Jul; 22(1):70-2. PubMed ID: 12842331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.
    Bratu S; Tolaney P; Karumudi U; Quale J; Mooty M; Nichani S; Landman D
    J Antimicrob Chemother; 2005 Jul; 56(1):128-32. PubMed ID: 15917285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.